Liu ZJ - Search Results

1

Aberrant Expressions of PSMD14 in Tumor Tissue are the Potential Prognostic Biomarkers for Hepatocellular Carcinoma after Curative Resection.

Xiong YM, Zhou F, Zhou JW, Liu F, Zhou SQ, Li B, Liu ZJ, Qin Y. Xiong YM, et al. Among authors: liu zj, liu f. Curr Genomics. 2023 Dec 28;24(6):368-384. doi: 10.2174/0113892029277262231108105441. Curr Genomics. 2023. PMID: 38327651 Free PMC article.

2

Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma.

He J, Huang Y, Liu Z, Zhao R, Liu Q, Wei L, Yu X, Li B, Qin Y. He J, et al. Gene. 2017 Sep 20;629:29-34. doi: 10.1016/j.gene.2017.07.077. Epub 2017 Jul 29. Gene. 2017. PMID: 28764977

3

[BORIS Regulates SOCS3 Expression Through Epigenetic Mechanisms in Human Hepatocellular Carcinoma Cells].

He JY, Liu QY, Wei L, Liu ZJ, Huang Y, Yu XQ, Li B, Qin Y. He JY, et al. Among authors: liu zj, liu qy. Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 Jan;49(1):1-7. Sichuan Da Xue Xue Bao Yi Xue Ban. 2018. PMID: 29737080 Chinese.

4

CAF-induced placental growth factor facilitates neoangiogenesis in hepatocellular carcinoma.

Liu Z, Chen M, Zhao R, Huang Y, Liu F, Li B, Qin Y. Liu Z, et al. Acta Biochim Biophys Sin (Shanghai). 2020 Jan 2;52(1):18-25. doi: 10.1093/abbs/gmz134. Acta Biochim Biophys Sin (Shanghai). 2020. PMID: 31828297 Free article.

5

AMPKα2/HNF4A/BORIS/GLUT4 pathway promotes hepatocellular carcinoma cell invasion and metastasis in low glucose microenviroment.

Huang Y, Xian L, Liu Z, Wei L, Qin L, Xiong Y, Hu L, Zhou S, Fu Q, Li B, Qin Y. Huang Y, et al. Biochem Pharmacol. 2022 Sep;203:115198. doi: 10.1016/j.bcp.2022.115198. Epub 2022 Aug 6. Biochem Pharmacol. 2022. PMID: 35940258

6

BORIS variant SF2(C2/A4) promotes the malignant development of liver cancer by activating epithelial-mesenchymal transition and hepatic stellate cells.

Wei L, Liu Z, Qin L, Xian L, Chen K, Zhou S, Hu L, Xiong Y, Li B, Qin Y. Wei L, et al. Mol Carcinog. 2023 Jun;62(6):731-742. doi: 10.1002/mc.23520. Epub 2023 Mar 17. Mol Carcinog. 2023. PMID: 36929051

7

Detection of promoter methylation status of suppressor of cytokine signaling 3 (SOCS3) in tissue and plasma from Chinese patients with different hepatic diseases.

Wei L, Huang Y, Zhao R, Zhang J, Liu Q, Liang W, Ding X, Gao B, Li B, Sun C, He J, Yu X, Liu Z, Sun A, Qin Y. Wei L, et al. Clin Exp Med. 2018 Feb;18(1):79-87. doi: 10.1007/s10238-017-0473-2. Epub 2017 Sep 26. Clin Exp Med. 2018. PMID: 28951980

8

Knockdown of CTCF reduces the binding of EZH2 and affects the methylation of the SOCS3 promoter in hepatocellular carcinoma.

Wei L, Liu Q, Huang Y, Liu Z, Zhao R, Li B, Zhang J, Sun C, Gao B, Ding X, Yu X, He J, Sun A, Qin Y. Wei L, et al. Int J Biochem Cell Biol. 2020 Mar;120:105685. doi: 10.1016/j.biocel.2020.105685. Epub 2020 Jan 7. Int J Biochem Cell Biol. 2020. PMID: 31917284

9

A genetic variant in the promoter of CD46 is associated with the risk and prognosis of hepatocellular carcinoma.

Liu F, Luo L, Liu Z, Wu S, Zhang W, Li Q, Peng Y, Wei Y, Li B. Liu F, et al. Mol Carcinog. 2020 Nov;59(11):1243-1255. doi: 10.1002/mc.23252. Epub 2020 Sep 1. Mol Carcinog. 2020. PMID: 32869896

10

BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells.

Liu Q, Chen K, Liu Z, Huang Y, Zhao R, Wei L, Yu X, He J, Liu J, Qi J, Qin Y, Li B. Liu Q, et al. Cancer Lett. 2017 Sep 10;403:165-174. doi: 10.1016/j.canlet.2017.06.017. Epub 2017 Jun 20. Cancer Lett. 2017. PMID: 28645561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,594 results

Search Page

Filters